Zhao W, Li L, Fu X, Chang Y, et al. A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma. Cancer 2026;132:e70247.
PMID: 41485126